Ovum Pick-Up Needle Single Lumen

Product Specification Product Show Egg retrieval is an invasive operation, and the complications mainly include the following aspects: 1. Bleeding, including blood vessel bleeding inside the ovary and near the ovary; 2. If the puncture passes through the bladder, it may cause bladder damage,...

Send Inquiry

Description

Product Specification

Product name	Ovum Pick-Up Needle Single Lumen
material	Stainless steel, etc.
Intended Use	OPU Needles are intended to puncture into the vaginal wall and obtain oocytes from ovarian follicles.
Product Feature	Made of top quality medical steel, with good tenacity and strength, easy to operate. Designed triple-cut blade provides sharp puncture, reduce pain and bleeding. Polished inner wall, minimize the risk of oocyte damage. Different gauge and specifications for choose.
Size	16G, 17G, 18G, 19G or Custom Size
Color	Blue, Green, Red or Custom Color
Custom feature	According to your 2D/3D Drawing or sample provided
Package	Polybag,carton packaging, and other tailor-made packing as per customers' requirements.
Certification	ISO9001:2015, SGS, ISO13485

Product Show

Egg retrieval is an invasive operation, and the complications mainly include the following aspects:

1. Bleeding, including blood vessel bleeding inside the ovary and near the ovary;

2. If the puncture passes through the bladder, it may cause bladder damage, such as blood volume, bladder inflammation, etc.;

3. If there is intestinal damage, it may cause complications such as abdominal pain and abnormal stool;

4. Because the puncture needle is inserted from the vagina, it may cause pelvic infection.

The above are the main complications of puncture oocyte retrieval surgery, but in general, the probability of complications of puncture surgery is relatively small. Most patients are more worried about whether the egg retrieval operation will cause premature ovarian failure, ovarian dysfunction, etc. In fact, the retrieved eggs will be atresia during the cycle, and they are removed after stimulation by exogenous drugs, which does not increase the occurrence of premature ovarian failure. Or the risk of complications such as diminished ovarian reserve.